Overencapsulating tablets can provide several benefits such as maintaining blinding during clinical trials. Scientists have wondered, however, whether the technique affects tablets’ in vitro or in vivo disintegration or dissolution. In this white paper the authors examined the disintegration and dissolution profile of overencapsulating tablets.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center